ArticleJournal of nanobiotechnology2025

Cross-protection against homo and heterologous influenza viruses via intranasal administration of an HA chimeric multiepitope nanoparticle vaccine.

Yongqiang Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.